FDA Rejects Sanofi-Aventis Drug Application
Pharmaceutical giant Sanofi-Aventis suffered a blow this week when the U.S. Food and Drug Administration refused to approve its cardiovascular drug, Multaq....To view the full article, register now.
Already a subscriber? Click here to view full article